Demonstrated Solid-State Stability of Parathyroid Hormone PTH(1–34) Coated on a Novel Transdermal Microprojection Delivery System
暂无分享,去创建一个
[1] M. Cormier,et al. Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology , 2001, Pharmaceutical Research.
[2] G. Dalsky,et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. , 2005, Archives of internal medicine.
[3] L. Fraenkel,et al. Patient treatment preferences for osteoporosis. , 2006, Arthritis and rheumatism.
[4] A. Frelinger,et al. Oxidized forms of parathyroid hormone with biological activity. Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18. , 1984, The Journal of biological chemistry.
[5] S. Boonen,et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. , 2007, The New England journal of medicine.
[6] R. Borchardt,et al. Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.
[7] M. Cormier,et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. , 2006, Vaccine.
[8] Dennis M Black,et al. Femoral Bone Strength and Its Relation to Cortical and Trabecular Changes After Treatment With PTH, Alendronate, and Their Combination as Assessed by Finite Element Analysis of Quantitative CT Scans , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] L. Fraenkel,et al. Patient willingness to take teriparatide. , 2007, Patient education and counseling.
[10] A. Frelinger,et al. The role of the methionine residues in the structure and function of parathyroid hormone. , 1986, Archives of biochemistry and biophysics.
[11] J. Zull,et al. Effect of methionine oxidation and deletion of amino-terminal residues on the conformation of parathyroid hormone. Circular dichroism studies. , 1990, The Journal of biological chemistry.
[12] M. Staples,et al. Long-term Stability and in vitro Release of hPTH(1–34) from a Multi-reservoir Array , 2008, Pharmaceutical Research.
[13] J. Matriano,et al. Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization , 2004, Pharmaceutical Research.
[14] Y. Nabuchi,et al. The Stability and Degradation Pathway of Recombinant Human Parathyroid Hormone: Deamidation of Asparaginyl Residue and Peptide Bond Cleavage at Aspartyl and Asparaginyl Residues , 1997, Pharmaceutical Research.
[15] J. Finkelstein,et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.
[16] Mahmoud Ameri,et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.